Login / Signup

Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC.

Jessica FreydmanLynnette HenshawJasmine V PatelClaire E SmithPeter C Everett
Published in: The Annals of pharmacotherapy (2021)
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • advanced non small cell lung cancer
  • brain metastases
  • tyrosine kinase